Viewing Study NCT04546633


Ignite Creation Date: 2025-12-25 @ 3:01 AM
Ignite Modification Date: 2026-03-11 @ 5:34 AM
Study NCT ID: NCT04546633
Status: COMPLETED
Last Update Posted: 2024-09-25
First Post: 2020-09-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy, Safety and Tolerability of KAF156 in Combination With Lumefantrine Solid Dispersion Formulation (LUM-SDF) in Pediatric Population With Uncomplicated Plasmodium Falciparum Malaria
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Uncomplicated Plasmodium Falciparum Malaria View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Plasmodium falciparum malaria View
None KAF156 View
None Lumefantrine Solid Dispersion Formulation View
None LUM-SDF View
None children View